课题基金 / 基金详情

ISOPRENYLATION OF RAS AND OTHER PROTEINS IN YEAST

ISOPRENYLATION OF RAS AND OTHER PROTEINS IN YEAST
酵母中 RAS 和其他蛋白质的异戊二烯化
批准号:
2625435
负责人:
Fuyuhiko Tamanoi
金额:
$30.95万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-06-01 至 2003-02-28

项目摘要

项目成果

Fuyuhiko Tamanoi的其他基金

相似基金

相关文献

中文摘要
翻译
通过添加法尼基对蛋白质进行修饰
英文摘要
Modification of proteins by the addition of a farnesyl groups has been shown to be critical for the function of proteins such as Ras. This facilitates membrane association of Ras which is required for its transforming activity. The modification is catalyzed by protein farnesyltransferase which recognizes the C-terminal CAAX motif of farnesylated proteins. These studies culminated in the development of farnesyltransferase inhibitors which exhibit remarkable ability to block the growth of human tumor cells. Characterization of the effects of these inhibitors, however, has raised the possibility that proteins other than Ras are targets of the inhibitors. In addition, a growing number of G-proteins such as Rheb, RhoB and RhoE have been shown to be farnesylated. These observations lead to a question how many proteins are farnesylated and what their physiological functions are. Our long term objective is to address these questions. Recent determination of the entire sequence of the yeast genome provides a unique opportunity to explore these issues. For the first time in the study of farnesylation, we can obtain a complete picture of farnesylated proteins in an eukaryotic organism. By searching for potentially farnesylated proteins using the yeast protein database, we identified 22 proteins ending with the CAAX motif. Of these, 14 are newly identified proteins or partially characterized proteins. We will take a targeted approach to characterize these proteins. First, we will focus on two G-proteins, Rheb and Rho3. Rheb is of particular interest, since its human counterpart is upregulated in a variety of human tumor cells, and has recently been shown to be farnesylated. We will carry out gene disruption as well as expression of mutant proteins to gain insights into the function of this G-protein. The other is Rho3 which plays a critical role in the polarized growth of yeast cells, apparently through its action on actin cytoskeleton and membrane fusions. We will investigate the significance of farnesylation on the function of Rho3. Finally, a systematic gene disruption study will be carried out to identify new farnesylated proteins which are essential. Our study will be the first full scale attempt to characterize farnesylated proteins in an eukaryotic organism. The results obtained should dramatically widen our understanding of protein farnesylation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Signal Transduction and Therapeutics
FASEB Summer Conference, July 20-25, 2002
NEUROFIBROMATOSIS TYPE 1 GENE PRODUCT
NEUROFIBROMATOSIS TYPE I GENE PRODUCT
国内基金
海外基金
基于菌体蛋白泄漏探究超高压对酿酒酵母Saccharomyces cerevisiae烯醇化酶致敏性的影响
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    59万元
  • 批准年份:
    2021
  • 负责人:
    孙爱东
  • 依托单位:
Saccharomyces cerevisiae NJWGYH30566产赤藓糖醇的辅酶工程及调控机理
  • 批准号:
    31171644
  • 项目类别:
    面上项目
  • 资助金额:
    64.0万元
  • 批准年份:
    2011
  • 负责人:
    胡永红
  • 依托单位:
3-甲硫基丙醇的Saccharomyces cerevisiae关键代谢分子调控机制研究
  • 批准号:
    31071593
  • 项目类别:
    面上项目
  • 资助金额:
    36.0万元
  • 批准年份:
    2010
  • 负责人:
    王成涛
  • 依托单位:
新疆慕萨莱思Saccharomyces cerevisiae发酵特性研究
  • 批准号:
    31060223
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    27.0万元
  • 批准年份:
    2010
  • 负责人:
    朱丽霞
  • 依托单位: